NASDAQ:YI

111 (YI) Stock Price, News & Analysis

$1.01
-0.04 (-3.81%)
(As of 05:13 PM ET)
Today's Range
$1.00
$1.04
50-Day Range
$0.97
$1.53
52-Week Range
$0.97
$3.36
Volume
18,948 shs
Average Volume
70,832 shs
Market Capitalization
$84.35 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
YI stock logo

About 111 Stock (NASDAQ:YI)

111, Inc., together with its subsidiaries, operates an integrated online and offline platform in the healthcare market in the People's Republic of China. It operates through two segments, B2C and B2B. The company sells medical and wellness products through online retail, and wholesale and retail pharmacies, as well as provides value-added services that include online consultation services and electronic prescription services to consumers. It offers prescription and over-the counter drugs, including western and traditional Chinese medicines; nutritional supplements, such as vitamins and dietary products; contact lenses; medical supplies and devices comprising bandages and thermometers; and personal care products consisting of skin care, birth control, sexual wellness products, and baby products. The company also operates an online marketplace where third-party sellers can directly sell to pharmacies; provides online loan application services to the clients of 1 Pharmacy, which include pharmacies and wholesalers; and data and supply chain integration services. In addition, it offers warehousing, logistics, procurement, research and development, and consulting services; and software development and information technology support services. The company operates offline retail pharmacies under the Yi Hao Pharmacy brand name in Guangzhou, Tianjin, Kunshan, Chongqing, and Wuhan provinces. It serves pharmacies, pharmaceutical companies, medical professionals, and insurance companies. The company was formerly known as New Peak Group and changed its name to 111, Inc. in April 2018. 111, Inc. was founded in 2010 and is headquartered in Shanghai, the People's Republic of China.

YI Stock Price History

YI Stock News Headlines

Mysterious Gold Leverage Just Announced
World's biggest multibillionaire investor group is buying THIS by the tons Most folks have completely missed the fact that there's one group of investors so powerful they're literally buying ONE THING by the tons… Stacking it in their locked vaults on pallets in record numbers.
Mysterious Gold Leverage Just Announced
World's biggest multibillionaire investor group is buying THIS by the tons Most folks have completely missed the fact that there's one group of investors so powerful they're literally buying ONE THING by the tons… Stacking it in their locked vaults on pallets in record numbers.
Rapid Recap: Bucks 101, Grizzlies 111
111, Inc. (NASDAQ:YI) Q4 2023 Earnings Call Transcript
YI Stock Earnings: 111 Reported Results for Q4 2023
See More Headlines
Receive YI Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for 111 and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
3/21/2024
Today
4/25/2024
Next Earnings (Estimated)
6/20/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Drug stores & proprietary stores
Sub-Industry
N/A
Fax
N/A
Employees
1,657
Year Founded
N/A

Profitability

Net Income
$-43,070,000.00
Pretax Margin
-2.36%

Debt

Sales & Book Value

Annual Sales
$14.99 billion
Book Value
($1.00) per share

Miscellaneous

Free Float
46,853,000
Market Cap
$85.19 million
Optionable
Optionable
Beta
0.38
12 Stocks Corporate Insiders are Abandoning Cover

If a company's CEO, COO, and CFO were all selling shares of their stock, would you want to know?

Get This Free Report

Key Executives

  • Dr. Gang Yu (Age 65)
    Co-Founder & Executive Chairman
  • Mr. Junling Liu (Age 59)
    Co-Founder, Acting CFO, Chairman & CEO
  • Mr. Haihui Wang
    Co-Chief Operating Officer
  • Mr. Pengcheng Zhu
    Co-Chief Operating Officer
  • Monica Mu
    IR Director
  • Mr. Anfeng Guo
    Chief Innovation Officer
  • Mr. Yang Chen (Age 53)
    CFO at Yaofang Information Technology (Shanghai) Co., Ltd.
  • Mr. Alex Liu
    Finance Director

YI Stock Analysis - Frequently Asked Questions

How have YI shares performed in 2024?

111's stock was trading at $1.55 on January 1st, 2024. Since then, YI shares have decreased by 34.2% and is now trading at $1.02.
View the best growth stocks for 2024 here
.

Are investors shorting 111?

111 saw a decrease in short interest in the month of April. As of April 15th, there was short interest totaling 15,200 shares, a decrease of 49.0% from the March 31st total of 29,800 shares. Based on an average daily volume of 65,600 shares, the days-to-cover ratio is currently 0.2 days.
View 111's Short Interest
.

When is 111's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Thursday, June 20th 2024.
View our YI earnings forecast
.

How were 111's earnings last quarter?

111, Inc. (NASDAQ:YI) issued its quarterly earnings data on Thursday, March, 21st. The company reported ($0.34) earnings per share (EPS) for the quarter. The business had revenue of $578.69 million for the quarter.

What other stocks do shareholders of 111 own?

Based on aggregate information from My MarketBeat watchlists, some companies that other 111 investors own include AbbVie (ABBV), Gilead Sciences (GILD), El Pollo Loco (LOCO), Noodles & Company (NDLS), Pfizer (PFE), Revolve Group (RVLV), Soleno Therapeutics (SLNO) and Chanticleer (BURG).

When did 111 IPO?

111 (YI) raised $140 million in an initial public offering (IPO) on Wednesday, September 12th 2018. The company issued 9,300,000 shares at a price of $14.00-$16.00 per share. J.P. Morgan, Citigroup and CICC served as the underwriters for the IPO.

How do I buy shares of 111?

Shares of YI stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NASDAQ:YI) was last updated on 4/25/2024 by MarketBeat.com Staff

From Our Partners